Your browser doesn't support javascript.
loading
Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China.
Liu, Xiaoran; Davis, Andrew A; Xie, Feng; Gui, Xinyu; Chen, Yifei; Zhang, Qiang; Gerratana, Lorenzo; Zhang, Youbin; Shah, Ami N; Behdad, Amir; Wehbe, Firas; Huang, Yong; Yu, Jianjun; Du, Pan; Jia, Shidong; Li, Huiping; Cristofanilli, Massimo.
Afiliação
  • Liu X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Fu-Cheng road No. 52, Hai-Dian District, Beijing, 100142, China.
  • Davis AA; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Xie F; Department of Medicine, Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
  • Gui X; Huidu (Shanghai) Medical Sciences, Ltd., Shanghai, China.
  • Chen Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Fu-Cheng road No. 52, Hai-Dian District, Beijing, 100142, China.
  • Zhang Q; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Fu-Cheng road No. 52, Hai-Dian District, Beijing, 100142, China.
  • Gerratana L; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Zhang Y; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Shah AN; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Behdad A; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Wehbe F; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Huang Y; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Yu J; Huidu (Shanghai) Medical Sciences, Ltd., Shanghai, China.
  • Du P; Huidu (Shanghai) Medical Sciences, Ltd., Shanghai, China.
  • Jia S; Predicine, Inc., Hayward, CA, USA.
  • Li H; Huidu (Shanghai) Medical Sciences, Ltd., Shanghai, China.
  • Cristofanilli M; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Fu-Cheng road No. 52, Hai-Dian District, Beijing, 100142, China. huipingli2012@hotmail.com.
Breast Cancer Res Treat ; 190(2): 213-226, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34471951

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Ácidos Nucleicos Livres / DNA Tumoral Circulante Tipo de estudo: Risk_factors_studies Limite: Female / Humans País como assunto: America do norte / Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Ácidos Nucleicos Livres / DNA Tumoral Circulante Tipo de estudo: Risk_factors_studies Limite: Female / Humans País como assunto: America do norte / Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article